Robotic esophagectomy yields more lymph nodes than laparoscopic approach

A phase 3 randomized trial across four European centers compared robot-assisted minimally invasive esophagectomy (RAMIE) with conventional minimally invasive esophagectomy (MIE) in 202 patients undergoing transthoracic esophagectomy for esophageal or esophagogastric junction adenocarcinoma. The trial reported a significantly higher median number of resected lymph nodes with RAMIE versus MIE (36 vs 32; P=.005), with similar luminal R0 resection rates, postoperative complications, 90-day mortality, and 1-year survival between groups. The authors concluded that robotic esophagectomy achieved more extensive lymphadenectomy with comparable surgical safety.

Most relevant for: Patients undergoing surgical resection for esophageal or esophagogastric junction adenocarcinoma.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.